Related Experiment Video
Updated: Feb 15, 2026

Dissection of Larval CNS in Drosophila Melanogaster
Published on: November 9, 2006
IL-1β enables CNS access to CCR2hi monocytes and the generation of pathogenic cells through GM-CSF released by CNS
Alexandre Paré1,2, Benoit Mailhot1,2, Sébastien A Lévesque1,2
1Centre de Recherche du Centre Hospitalier Universitaire de Québec, Université Laval, Québec, QC G1V 4G2, Canada.
Abstract:
Molecular interventions that limit pathogenic CNS inflammation are used to treat autoimmune conditions such as multiple sclerosis (MS). Remarkably, IL-1β-knockout mice are highly resistant to experimental autoimmune encephalomyelitis (EAE), an animal model of MS. Here, we show that interfering with the IL-1β/IL-1R1 axis severely impairs the transmigration of myeloid cells across central nervous system (CNS) endothelial cells (ECs). Notably, we report that IL-1β expression by inflammatory CCR2hi monocytes favors their entry into the spinal cord before EAE onset. Following activation with IL-1β, CNS ECs release GM-CSF, which in turn converts monocytes into antigen-presenting cells (APCs). Accordingly, spinal cord-infiltrated monocyte-derived APCs are associated with dividing CD4+ T cells. Factors released from the interaction between IL-1β-competent myeloid cells and CD4+ T cells are highly toxic to neurons. Together, our results suggest that IL-1β signaling is an entry point for targeting both the initiation and exacerbation of neuroinflammation.
Insights
Targeting the IL-1β/IL-1R1 pathway blocks myeloid cell entry into the CNS, preventing neuroinflammation in models of multiple sclerosis (MS). This pathway is crucial for initiating and worsening central nervous system (CNS) inflammation.
Area of Science:
- Neuroimmunology
- Molecular and Cellular Biology
Background:
- Autoimmune conditions like multiple sclerosis (MS) involve central nervous system (CNS) inflammation.
- Interleukin-1 beta (IL-1β) plays a critical role in experimental autoimmune encephalomyelitis (EAE), an MS animal model.
Purpose of the Study:
- To investigate the role of the IL-1β/IL-1R1 axis in myeloid cell infiltration and neuroinflammation during EAE.
- To identify molecular targets for treating CNS autoimmune diseases.
Main Methods:
- Utilized IL-1β-knockout mice to study resistance to EAE.
- Examined myeloid cell transmigration across CNS endothelial cells (ECs).
- Analyzed the expression of IL-1β, CCR2, GM-CSF, and CD4+ T cells in the spinal cord.
Main Results:
- Interference with the IL-1β/IL-1R1 axis significantly reduced myeloid cell migration into the CNS.
- IL-1β produced by inflammatory monocytes promotes their entry into the spinal cord before EAE onset.
- Activated CNS ECs release GM-CSF, converting monocytes into antigen-presenting cells (APCs) that interact with CD4+ T cells, leading to neurotoxicity.
Conclusions:
- IL-1β signaling is a critical regulator of myeloid cell entry into the CNS and subsequent neuroinflammation.
- Targeting the IL-1β/IL-1R1 axis offers a potential therapeutic strategy for MS and other neuroinflammatory diseases.
Related Concept Videos
CNS Depressants: Alcohol and Nicotine
CNS Depressants: Barbiturates and Benzodiazepines
CNS Stimulants: Psychedelic Agents
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Energy-releasing Steps of Glycolysis
The first energy-releasing step—the 6th step of glycolysis...
Plant Cells and Tissues

